Implications of imatinib mesylate for hematopoietic stem cell transplantation

Seminars in Hematology

Volumn 38, Issue 3 SUPPL. 8, 2001, Pages 28-34

  Goldman, John ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CYTARABINE; IMATINIB; UNCLASSIFIED DRUG;

ALGORITHM; ALLOGENIC BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKEMIA REMISSION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RELAPSE; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 0034873546     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0037-1963(01)90115-5     Document Type: Review

References (19)

1. Chronic myelogenous leukemia: Biology and therapy
2. Chronic myeloid leukemia
3. 1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin
4. Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia
5. Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation
6. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program
7. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
8. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
9. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: The case for tailored graft-versus-host disease prophylaxis
10. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
11. Chronic myeloid leukemia
12. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation
13. Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplantation define the risk of subsequent relapse
14. Hematopoietic stem cell transplants after reduced intensity conditioning regiment (RIHSCT): Report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT)
15. Autologous stem cell transplantation in chronic myelogenous leukemia: A retrospective analysis of the European Group for Bone Marrow Transplantation
16. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia
17. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha rherapy
18. Durability of responses following donor lymphocyte infusions for patients who relapse after allografting for chronic myeloid leukemia
19. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia